United Therapeutics Corp
UTHR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001082554
In the last 90 days, United Therapeutics Corp insiders filed 0 open-market purchases and 72 sales; 886 institutions reported holding it in 13F filings for Q2 2026, worth $22.6B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding United Therapeutics Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 626 | 12 | 673 | +59 |
| Shares | 43.8M | 68.8K | 44.2M | +408.7K (+0.9%) |
| Value | $15.7B | $24.6M | $15.6B | −$68.6M (−0.4%) |
12 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (104)
Institutions that held United Therapeutics Corp at the end of Q4 2024 but not at the end of Q3 2024.
Showing the largest 100 of 104 by value.
Sold out (45)
Institutions that held United Therapeutics Corp at the end of Q3 2024 and filed for Q4 2024 without it.
Not filed for Q4 2024 yet (12)
Institutions that held United Therapeutics Corp at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 35,751 | $12.8M |
| Tri Ri Asset Management Corp | 21,448 | $7.69M |
| Raymond James Financial Services Advisors, Inc. | 6,429 | $2.30M |
| Brophy Wealth Management, LLC | 2,258 | $809.2K |
| B. Metzler seel. Sohn & Co. Holding AG | 960 | $344.0K |
| GYL Financial Synergies, LLC | 942 | $337.6K |
| Rakuten Investment Management, Inc. | 771 | $276.4K |
| FinTrust Capital Advisors, LLC | 121 | $43.4K |
| ClariVest Asset Management LLC | 77 | $24.5K |
| Naples Money Management LLC | 10 | $3.58K |
| VitalStone Financial, LLC | 9 | $3.23K |
| Abich Financial Wealth Management LLC | 7 | $2.51K |